IQV news

IQVIA reported strong Q3 2026 results with revenue, Adjusted EBITDA, and EPS all beating high-end estimates and exceeding prior-year levels, alongside record bookings and raised full-year guidance.

IQVIA reported second-quarter 2026 revenue of $4.37 billion, up 8.7%, and raised full-year guidance. The company also revealed R&D Solutions booked a record $3.15 billion in net new bookings.

IQVIA's subsidiary priced a €950 million offering of senior notes due 2033 with a 4.625% coupon to refinance existing debt. The offering demonstrates the company's debt capital markets access and will help optimize its capital structure.

IQVIA Inc. announced a €950 million senior notes offering due 2033 to refinance existing debt and cover offering expenses. The debt offering provides capital management flexibility for the healthcare research services company.